Ikoma, Japan

Kenzo Toyoshima

This inventor holds 2 USPTO granted patents. Top assignees: Boehringer Ingelheim International Gmbh, Fujisawa Pharmaceutical Company, Ltd.. Active years: 1992-2015.


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1992-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kenzo Toyoshima: Innovator in Pharmaceutical Formulations

Introduction

Kenzo Toyoshima is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents, Toyoshima's work has the potential to enhance the efficacy of various medications.

Latest Patents

Toyoshima's latest patents include a solid telmisartan pharmaceutical formulation. This composition comprises 3 wt. % to 50 wt. % telmisartan dispersed in a dissolving matrix. Another notable patent is a novel pharmaceutical composition that combines exifone and certain water-soluble cellulose derivatives. This mixture exhibits surprisingly improved solubility and bioavailability, which can lead to better therapeutic outcomes.

Career Highlights

Throughout his career, Kenzo Toyoshima has worked with prominent companies in the pharmaceutical industry. He has been associated with Boehringer Ingelheim International GmbH and Fujisawa Pharmaceutical Company, Ltd. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Some of Toyoshima's coworkers include Sawada Takeshi and Nobumitsu Nakahasi. Their collaboration has likely played a role in advancing the innovative projects they have worked on together.

Conclusion

Kenzo Toyoshima's contributions to pharmaceutical formulations demonstrate his commitment to improving drug efficacy and patient outcomes. His innovative patents reflect a deep understanding of pharmaceutical science and a dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…